Quarterly report pursuant to Section 13 or 15(d)

Related Party Transactions

v2.4.0.8
Related Party Transactions
3 Months Ended
Sep. 30, 2013
Related Party Transactions [Abstract]  
Related Party Transactions Disclosure [Text Block]
11.  Related Party Transactions
 
In January 2012, the Company entered into an agreement with a vendor in which iBio’s President is a minority stockholder. The vendor performs laboratory feasibility analyses of gene expression, protein purification and preparation of research samples. The transaction has been conducted on an arm’s length basis at market terms. The accounts payable balance includes amounts due to this vendor of approximately $109,000 and $93,000 as of September 30, 2013 and June 30, 2013, respectively. Research and development expenses related to this vendor were approximately $153,000 and $95,000 for the three months ended September 30, 2013 and 2012, respectively.